I want to thank the members of the Strategic Plan Task Force, which included members of the Executive Committee, Board of Directors, committee chairs and members at large from both academia and clinical work settings.
I want to thank the always supportive and flexible ACR and ARHP staff, as well, for their conscientious assistance.
Your input and engagement is welcome as we put the plan into action. Follow Rheumatology or your e-newsletters (ACR@Work and ACR eNewsRheum) for updates. Give us your feedback. Sign up for volunteer roles in the area that appeals most to you. Together, we will empower rheumatology professionals to excel in our specialty and use a strategic, data-driven, metrics-measured approach to reach our goals in five years.
Sharad Lakhanpal, MBBS, MD, is in private practice at Rheumatology Associates and a clinical professor of internal medicine at the University of Texas Southwestern Medical School, both in Dallas, where he has lived and worked since 1986. He is also the 80th president of the ACR (2016–17).
Strategic Plan Task Force
Task Force Co-Chair
Jane Kang, MD, MS;
Task Force Co-Chair
Charles King II, MD;
Abby Abelson, MD;
Stacy Ardoin, MD;
Joel Block, MD;
David Daikh, MD, PhD;
Sarah Doaty, MD;
Afton Hassett, PsyD;
Mike Holers, MD;
Tim Laing, MD;
Paula Marchetta, MD, MBA;
Zsuzsanna McMahan, MD, MHS;
Chris Mecoli, MD;
Eli Miloslavsky, MD;
Sandra Mintz, MSN, RN;
Seetha Monrad, MD;
Melissa Griffith, MD;
Jennifer Horonjeff, PhD;
Gabriela Schmajuk, MD, MS;
Swamy Venturupalli, MD;
Zach Wallace, MD;
Kelly Weselman, MD;
Doug White, MD, PhD;
Angus Worthing, MD; and
Sharad Lakhanpal, MBBS, MD.